Melanoma antigens are biomarkers for ipilimumab response-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Melanoma antigens are biomarkers for ipilimumab response

Published:2016-09-21 Issue:2 Volume:31 Page:252-259
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Arenberger P.¹,Fialova A.¹,Gkalpakiotis S.¹,Pavlikova A.²,Puzanov I.³,Arenbergerova M.¹

Affiliation:

1. Department of Dermatovenereology; Third Faculty of Medicine; Charles University and Faculty Hospital of Kralovske Vinohrady; Prague Czech Republic

2. Institute for Laboratory Diagnostics; Faculty Hospital of Kralovske Vinohrady; Prague Czech Republic

3. Division of Hematology-Oncology; Vanderbilt University Medical Center; Nashville TN USA

Funder

Czech Ministry of Health

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.13940/fullpdf

Reference23 articles.

1. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010

2. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma;Robert;N Engl J Med,2011

3. Biomarkers for immunostimulatory monoclonal antibodies in combination strategies for melanoma and other tumor types;Ascierto;Clin Cancer Res,2013

4. Circulating tumour cells-monitoring treatment response in prostate cancer;Miyamoto;Nat Rev Clin Oncol,2014

5. Circulating tumor cells, disease progression, and survival in metastatic breast cancer;Cristofanilli;N Engl J Med,2004

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics, Pharmacodynamics, and Toxicology Aspects of Immunotherapeutics;Immunotherapy – A Novel Facet of Modern Therapeutics;2020-12-17

2. Biomarkers, measured during therapy, for response of melanoma patients to immune checkpoint inhibitors: a systematic review;Melanoma Research;2019-10

3. Melanoma and autoimmunity: spontaneous regressions as a possible model for new therapeutic approaches;Melanoma Research;2019-06

4. MiR-431 is a prognostic marker and suppresses cell growth, migration and invasion by targeting NOTCH2 in melanoma;EUR REV MED PHARMACO;2019

5. Biology of Cancer; From Cellular Cancerogenesis to Supracellular Evolution of Malignant Phenotype;Cancer Investigation;2018-05-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3